The combination of increased levels of IL-16 and caspase 3 activity has been reported in cerebrospinal fluid from patients with multiple sclerosis and experimental autoimmune encephalomyelitis, and is correlated with disease activity [37], [38]. This evidence concerns the gene IL16 and multiple sclerosis.